Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
Xylocaine 10 mg Spray.
| Pharmaceutical Form |
|---|
|
Non-sterile solution for topical application supplied in a pump spray, with nozzles for single use in an individual patient. |
Lidocaine 10 mg/metered dose.
Excipient(s) with known effect: Each depression also delivers 1 mg of propylene glycol (an excipient of the banana essence).
Also contains ethanol.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane. |
| List of Excipients |
|---|
|
Ethanol |
50 ml glass spray bottles (approx. 500 spray doses) with a metering spray pump. The package includes a single use plastic spray nozzle approximately 120 mm long. Additional short spray nozzles are available separately.
Each depression of the metered spray pump delivers 10 mg lidocaine base. The contents of the spray bottles are sufficient to provide approximately 500 sprays.
Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
PL 39699/0086
Date of first authorisation: 25th August 1989
Date of last renewal: 7th May 2002
| Drug | Countries | |
|---|---|---|
| XYLOCAINE | Japan |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.